Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
27 April 2013 - P914
Pharmacokinetic-pharmacodynamics (PK-PD) predict a high probability of efficacy for plazomicin against serious infections caused by carbapenem-resistant Enterobacteriaceae (CRE)
Sujata M. Bhavnani, S.A. Van Wart, A. Forrest, G.L. Drusano, S.M. Bhavnani*, C.C. Bulik, C.F. Kostrub, P.G. Ambrose, A. Louie (Latham, Orlando, South San Francisco, US)
27 April 2013 - P915
Use of pharmacokinetics-pharmacodynamics (PK-PD) and Monte Carlo simulation (MCS) analyses to support brilacidin (BRI) dose selection for patients with acute bacterial skin and skin structure infections (ABSSSI)
Sujata M. Bhavnani, S.M. Bhavnani*, J.P. Hammel, A. Forrest, M. Melhem, P. Sager, K.J. Tack, P.G. Ambrose, D.M. Jorgensen (Latham, San Francisco, Brighton, Radnor, US)
27 April 2013 - P916
Pharmacokinetic-pharmacodynamic (PK-PD) analyses for efficacy and safety of brilacidin (BRI) using data from patients with acute bacterial skin and skin structure infections (ABSSSI)
Sujata M. Bhavnani, S.M. Bhavnani*, J.P. Hammel, A. Forrest, M. Melhem, P. Sager, D.M. Jorgensen, P.G. Ambrose (Latham, San Francisco, Radnor, US)
27 April 2013 - P917
Population pharmacokinetic (PPK) analyses of brilacidin using data from healthy subjects and patients with acute bacterial skin and skin structure infections (ABSSSI)
Sujata M. Bhavnani, M. Melhem, C.M. Rubino, S.M. Bhavnani, A. Forrest*, D.K. Reynolds, D.M. Jorgensen, B. Korczak, P.G. Ambrose (Latham, Radnor, US)
27 April 2013 - P918
The pharmacokinetics (PK) and safety of plazomicin in subjects with renal impairment
Todd Clobes, V. Riddle, D. Cebrik, C. Kostrub, L. Ma*, K. Hillan (Crofton, San Francisco, South San Francisco, US)
27 April 2013 - P919
The effect of food and formulation on the pharmacokinetics of GSK1322322 in healthy subjects
Odin Naderer, O.J. Naderer*, L.S. Jones, J.Z. Zhu, M.D. Coffin, M.T. Kurtinecz, E.F. Dumont (Research Triangle Park, Upper Merion, Upper Providence, US)
27 April 2013 - P920
Pharmacokinetics/pharmacodynamics (PK/PD) of peptide deformylase inhibitor GSK1322322 against Staphylococcus aureus in a rat abscess model
Thomas Lewandowski, T. Lewandowski*, J. Hoover, S. Rittenhouse (Collegeville, US)
27 April 2013 - P921
Lack of pharmacokinetic drug interaction of tedizolid phosphate with pseudoephedrine in healthy subjects
Johnna Simoes, S. Flanagan*, S. Minassian, K.A. Munõz, H. Dreskin, E. Fang, P. Prokocimer (San Diego, US)
27 April 2013 - P922
Dialysability of antiinfective drugs: an in vitro model with continuous haemodialysis
Otto Roman Frey, A.C. Röhr*, O.R. Frey, A. Köberer, T. Fuchs, J.A. Preisenberger, S.L. Helbig, A. Brinkmann (Heidenheim, DE)
27 April 2013 - P923
Micafungin pharmacokinetics during continuous venovenous haemofiltration in critically ill patients
Emilio Maseda, E. Maseda*, S. Grau, M.-J. Villagran, C. Hernandez-Gancedo, A. Lopez-Tofiño, L. Aguilar, S. Luque, F. Gilsanz (Madrid, Barcelona, ES)
27 April 2013 - P924
Cerebrospinal fluid concentration of ceftazidime administered by continuous infusion at high dose in ventriculitis associated with external ventricular drainage
Patricio Mas-Serrano, P. Más-Serrano*, J.A. Navarro-Martinez, C. Pastor-Cerdan, C. Ferrero, F. Martinez-Adsuar, E. Climent, I. Gascon, E. Merino, G. Riera, R. Nalda-Molina, A. Ramon-Lopez, R. Company-Teuler, J. Selva (Alicante, Benidorm, Elche, ES)
27 April 2013 - P925
Target attainment rates (TAR) and cumulative fraction of response (CFR) in plasma for ceftolozane in a simulated population of patients with complicated intra-abdominal (cIAI) and urinary tract infection (cUTI)
Gurudatt Chandorkar, G Chandorkar*, J. Steenbergen, S. Mouksassi, D. Benziger (Lexington, US; Quebec, CA)
27 April 2013 - P926
DALI: defining antibiotic levels in intensive care unit patient. Variability of protein binding of teicoplanin and achievement of TDM targets
Jason Roberts, J. Roberts*, M. Bassetti, J. Dewaele, G. Dimopoulos, D. Koulenti, C. Martin, B. McWhinney, P. Montravers, S. Parker-Scott, J. Rello, A. Rhodes, B. Sipinkoski, T. Starr, V. Stove, J. Ungerer, S. Wallis, J. Lipman (Brisbane, AU; Genova, IT; Ghent, BE; Athens, GR; Marseille, FR; Paris, FR; Barcelona, ES; London, UK)
27 April 2013 - P927
Population pharmacokinetics of linezolid in diabetic patients with soft tissue infections: are standard doses adequate?
Iris K. Minichmayr, I.K. Minichmayr*, A. Schaeftlein, M. Zeitlinger, C. Kloft (Berlin, DE; Vienna, AT)
27 April 2013 - P928
Population pharmacokinetics of amikacine in ventilator-associated pneumonia
Charles Burdet, C. Burdet*, O. Pajot, C. Couffignal, L. Massias, L. Armand-Lefèvre, A. Foucrier, C. Laouénan, M. Wolff, F. Mentré (Paris, FR)
27 April 2013 - P929
Fluoroquinolone resistance in Escherichia coli: search for the optimal predictor using in vitro dynamic models
Alexander Firsov, E. Strukova, D. Shlykova, Y. Portnoy, S. Zinner, A. Firsov* (Moscow, RU; Cambridge, US)
27 April 2013 - P930
Pharmacodynamic interactions of tigecycline and colistin combination against Pseudomonas aeruginosa using microdilution checkerboard and time-kill method
Sophia Vourli, S. Vourli*, J. Meletiadis, T. Karonis, N. Siafakas, L. Zerva (Athens, GR)
27 April 2013 - P931
Whole-body physiologically-based pharmacokinetic model for colistin and colistimethate sodium (CMS) in five different animal species: mouse, rat, rabbit, baboon and pig
Salim Bouchene, S. Bouchene*, S. Marchand, L.E. Friberg, S. Björkman, W. Couet, M.O. Karlsson (Uppsala, SE; Poitiers, FR)
27 April 2013 - P932
Polymyxin B induces DNA breakage and mitochondrial morphology changes in rat kidney tubular cells
Mohammad Azad, M.A.K. Azad*, L. Whitehead, C. Nowell, K. Rogers, R.L. Nation, T. Velkov, J. Li (Melbourne, AU)
27 April 2013 - P933
Characterisation of semi-mechanistic pharmacokinetic-pharmacodynamic models of antibacterial activity via Monte Carlo simulations
Matthieu Jacobs, M. Jacobs*, N. Gregoire, W. Couet, J. Bulitta (Poitiers, FR; Melbourne, AU)
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.